Program of the 8th AMR Conference Here is a first glimpse of the conference sessions planned for 2024. More details and speaker names will be released in the next months. Conference Day 1Wednesday, 6 March 2024 Conference Day 2Thursday, 7 March 2024 Conference Day 1 Wednesday, 6 March 2024 09:00 – 11:00 Pre-conference meeting BEAM Alliance General Assembly 09:30 – 11:00 Pre-conference workshop tbd 11:30 – 13:00 Opening plenary How can we combat AMR globally? 13:00 – 14:00 Lunch break 14:00 – 15:30 Parallel sessions Taking actions on pull incentives Preclinical models to optimize translation to human Vaccines to keep AMR at bay 16:00 – 17:30 Parallel sessions Meaningful clinical trials: combining regulatory and clinical differentiation needs Novel disruptive approaches to fight AMR Roundtable: How to build bridges between human and animal health? 18:00 – 19:30 Start-up pitch Conference Day 2 Thursday, 7 March 2024 08:30 – 09:30 Plenary session A phage cocktail for breakfast? 10:00 – 11:30 Parallel sessions Tuberculosis: new tools against an old enemy New tricks to combat fungal infections Making the case for investing in AMR R&D 11:30 – 13:00 Lunch break 13:00 – 14:30 Parallel sessions Fast, reliable and cost-effective diagnostics Push funding: a lifeline for R&D Technology update 15:00 – 16:30 Parallel sessions Leveraging the power of diagnostics in clinical practice Greatest reach to the greatest need The true value of antimicrobial products 17:00 – 18:00 Closing plenary Future threats: Making the invisible visible BEAM Alliance program committee Marc Gitzinger CEO, BioVersys AG & President, BEAM Alliance Florence Séjourné CEO, Aurobac Therapeutics & Treasurer, BEAM Alliance Deepali Patel Director of international policy, AMR Action Fund